The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless products represents a significant regulatory problem for the FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to work as a sedative at substantial dosages6. The promises created by Nicotine River, ECBlend, and other distribu… Read More